Ballentine Partners’s SunOpta STKL Stock Holding History

Ballentine Partners’s Portfolio STKL Stock Details STKL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-45,762	Closed	-$297K	–	1124
2026 Q1	$297K	Buy	45,762 +25,631	+127%	+$145K	﹤0.01%	747
2025 Q4	$76.5K	Sell	20,131 -530	-3%	-$2.41K	﹤0.01%	980
2025 Q3	$121K	Sell	20,661 -5	-0%	-$31	﹤0.01%	970
2025 Q2	$120K	Buy	+20,666	New	+$109K	﹤0.01%	929
2025 Q1	–	Sell	-30,664	Closed	-$236K	–	989
2024 Q4	$236K	Buy	30,664 +8,652	+39%	+$61.2K	﹤0.01%	711
2024 Q3	$140K	Buy	22,012 +10,876	+98%	+$63.7K	﹤0.01%	779
2024 Q2	$60.1K	Buy	+11,136	New	+$65.4K	﹤0.01%	740

Ballentine Partners's STKL Position: Q2 2026 in Review

Ballentine Partners sold out of SunOpta (STKL) in Q2 2026, closing a stake of 45,762 shares — an estimated $297K sold.

Ballentine Partners first reported a position in STKL in Q2 2024 and held it in 7 quarters. The position peaked at $297K in Q1 2026. 0 funds tracked by Wall St. Rank hold STKL as of Q2 2026.

Ballentine Partners reported no remaining SunOpta position as of Q2 2026 after selling out during the quarter.
Ballentine Partners sold 45,762 SunOpta shares in Q2 2026, an estimated $297K.
Ballentine Partners first reported a position in SunOpta in Q2 2024 and held it in 7 quarters.
Ballentine Partners's SunOpta position peaked at $297K in Q1 2026.
0 funds tracked by Wall St. Rank held SunOpta as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.